3-(4-bromophenyl)-8-phenylmethanesulfonyl-1,4,8-triazaspiro[4.5]dec-3-en-2-one

ID: ALA5278742

Max Phase: Preclinical

Molecular Formula: C20H20BrN3O3S

Molecular Weight: 462.37

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC2(CCN(S(=O)(=O)Cc3ccccc3)CC2)N=C1c1ccc(Br)cc1

Standard InChI:  InChI=1S/C20H20BrN3O3S/c21-17-8-6-16(7-9-17)18-19(25)23-20(22-18)10-12-24(13-11-20)28(26,27)14-15-4-2-1-3-5-15/h1-9H,10-14H2,(H,23,25)

Standard InChI Key:  PYOPNNNPMJIIQA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -0.4625   -0.8983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2519   -0.4859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9664   -0.8983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9664   -1.7234    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2519   -2.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4625   -1.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6806   -2.1357    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3949   -1.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0974   -2.7189    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930   -2.8499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1767   -1.3107    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7951   -0.7397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4645   -0.0056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6409   -0.0978    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5917   -0.9532    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8769    0.7085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7017    0.7088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1121    1.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6997    2.1357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8790    2.1373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4628    1.4259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1120    2.8499    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    2.3949   -0.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6806   -0.4860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6814    0.3361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3958    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1073    0.3397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1121   -0.4845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  4  7  1  0
  7  8  1  0
  7  9  2  0
  7 10  2  0
  1 11  1  0
 11 12  1  0
 12 13  1  0
 14 13  2  0
  1 14  1  0
 12 15  2  0
 16 13  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 20 19  1  0
 16 21  1  0
 21 20  2  0
 19 22  1  0
  8 23  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 23 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5278742

    ---

Associated Targets(Human)

NEK2 Tchem Serine/threonine-protein kinase NEK2 (3514 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.37Molecular Weight (Monoisotopic): 461.0409AlogP: 2.69#Rotatable Bonds: 4
Polar Surface Area: 78.84Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.06CX Basic pKa: CX LogP: 3.29CX LogD: 3.29
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.76Np Likeness Score: -1.10

References

1. Bhuiyan AI, Choi AH, Ghoshal S, Adiele UA, Dana D, Choi JY, Fath KR, Talele TT, Pathak SK..  (2023)  Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening.,  88  [PMID:37094724] [10.1016/j.bmcl.2023.129288]

Source